Novel quinolone alkaloid in Evodia rutaecarpa, and preparation method, application and pharmaceutical composition of such quinolone alkaloid
A technology of quinolones and Evodia rutaecarpa, which is applied in the field of compound extraction and separation, can solve problems such as unclear mechanism of action, unstable curative effect, and complex components of traditional Chinese medicine, and achieve excellent neuroprotective effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Embodiment 1: The preparation method of new quinolone alkaloid compound 1 in Evodia rutaecarpa comprises the following steps:
[0028] 10 kg of Evodia rutaecarpa medicinal materials were reflux extracted with 90% ethanol for 3 times, each time for 2 hours, and the combined extracts were concentrated under reduced pressure to obtain an extract (800 g). After the extract was dispersed in water, it was extracted several times with petroleum ether, chloroform, and n-butanol in sequence, and the solvents were respectively recovered under reduced pressure. 32, 200, 320 g of each extract were obtained sequentially. Chloroform extract 200g was crudely separated by silica gel (200-300 mesh, 3 kg) column chromatography, CHCl 3 / CH 3 COCH 3 (100:1→1:100) gradient elution, each fraction 2000 ml, a total of 167 fractions were collected, and then 167 fractions were combined by TLC to obtain 5 fractions Fr (1-5) ; Fr.3 (30 g) was subjected to open ODS column chromatography (MeOH:...
Embodiment 2
[0029] Example 2: Application of the new quinolone alkaloid compound 1 in Evodia rutaecarpa in the preparation of drugs for the prevention and / or treatment of neurodegenerative diseases. The neurodegenerative diseases are stroke, dementia, neuroinflammation, heavy metal poisoning, and nerve agent poisoning. The dementia is Alzheimer's disease or vascular dementia.
[0030] The physicochemical and spectral data of the new quinolone alkaloids of Evodia rutaecarpa are as follows:
[0031] Yellow oil, ESI-MS m / z 256 [M+H] + . 1 H-NMR (CDCl 3 , 500 MHz) and 13 C-NMR (CDCl 3 , 125 MHz) see the table below for data
[0032] Table 1 Compound 1 1 H and 13 C-NMR data (CDCl 3 , J in Hz)
[0033]
[0034] a The signals were overlapped.
[0035] Pharmacological experiment
[0036] Test materials 1. Test drug: monomer compound of the present invention. 2. Positive control drug: Edaravone, provided by China National Institutes for Food and Drug Control. Purity > 98% by HP...
experiment example 1
[0037] Experimental example 1: Effect of the compound of the present invention on the survival state of rat cerebral cortex neurons and its protective effect in the model of neuron apoptosis induced by sodium nitroprusside
[0038] In the study of the effect of the compound on the survival state of neurons, the primary cultured rat cortical neurons (DIV-9) were divided into a control group and an administration group (10 μM), n=6; In the study of the protective effect of the apoptosis model, the primary cultured rat cortical neurons (DIV-7) were divided into control group, sodium nitroprusside (350 μM) model group, sodium nitroprusside (350 μM) + ida Lavone (100 μM) administration group, sodium nitroprusside (350 μM) + compound (10 μM) administration group, n =6. After administration, the cells were placed in a cell incubator to continue culturing for 24 hours, and the cell viability was measured by MTT method (570 nm). Taking the absorbance of the control group as the standa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com